FDA aims to support safe development of medical devices that implement machine learning through predetermined change control plans. Manufacturers no longer need to submit new marketing submissions for already-approved software functions. Engage early and transparency with patients is of the utmost importance.
Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?